Healthcare provider profile · identity verified

Abayneh Woldekidane, MD

Internal Medicine · PARKER, CO · NPI 1679738561

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	503	56
Levothyroxine Sodium	Levothyroxine Sodium	430	51
Atorvastatin Calcium	Atorvastatin Calcium	404	84
Furosemide	Furosemide	399	38
Gabapentin	Gabapentin	233	48
Amlodipine Besylate	Amlodipine Besylate	228	43
Tamsulosin Hcl	Tamsulosin Hcl	224	41
Lisinopril	Lisinopril	223	44
Metformin Hcl	Metformin Hcl	155	25
Losartan Potassium	Losartan Potassium	112	23
Potassium Chloride	Potassium Chloride	108	26
Pantoprazole Sodium	Pantoprazole Sodium	106	30
Carvedilol	Carvedilol	104	14
Sertraline Hcl	Sertraline Hcl	104	22
Duloxetine Hcl	Duloxetine Hcl	99	23
Mirtazapine	Mirtazapine	99	25
Hydralazine Hcl	Hydralazine Hcl	97	19
Metoprolol Tartrate	Metoprolol Tartrate	96	26
Metoprolol Succinate	Metoprolol Succinate	91	23
Quetiapine Fumarate	Quetiapine Fumarate	86	19
Ondansetron Hcl	Ondansetron Hcl	82	50
Trazodone Hcl	Trazodone Hcl	82	23
Enoxaparin Sodium	Enoxaparin Sodium	73	suppressed
Xarelto	Rivaroxaban	69	suppressed
Clopidogrel	Clopidogrel Bisulfate	67	14
Myrbetriq	Mirabegron	65	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	64	12
Spironolactone	Spironolactone	64	suppressed
Finasteride	Finasteride	63	12
Oxycodone Hcl	Oxycodone Hcl	61	38
Simvastatin	Simvastatin	57	suppressed
Jardiance	Empagliflozin	56	suppressed
Baclofen	Baclofen	55	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	51	12
Rosuvastatin Calcium	Rosuvastatin Calcium	50	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	48	25
Albuterol Sulfate Hfa	Albuterol Sulfate	46	23
Entresto	Sacubitril/Valsartan	46	suppressed
Levetiracetam	Levetiracetam	43	suppressed
Famotidine	Famotidine	42	14
Alendronate Sodium	Alendronate Sodium	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	suppressed
Daptomycin	Daptomycin	36	suppressed
Methocarbamol	Methocarbamol	36	20
Venlafaxine Hcl Er	Venlafaxine Hcl	35	11
Creon	Lipase/Protease/Amylase	33	suppressed
Meloxicam	Meloxicam	31	suppressed
Spiriva Respimat	Tiotropium Bromide	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	14
Prednisone	Prednisone	30	13
Albuterol Sulfate	Albuterol Sulfate	28	15
Allopurinol	Allopurinol	28	suppressed
Divalproex Sodium	Divalproex Sodium	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Olanzapine	Olanzapine	27	suppressed
Levofloxacin	Levofloxacin	26	18
Pregabalin	Pregabalin	26	12
Lokelma	Sodium Zirconium Cyclosilicate	25	suppressed
Risperidone	Risperidone	25	suppressed
Breyna	Budesonide/Formoterol Fumarate	24	11
Cephalexin	Cephalexin	24	16
Clonidine Hcl	Clonidine Hcl	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Acetic Acid	Acetic Acid	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	11
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Lactulose	Lactulose	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	12
Aripiprazole	Aripiprazole	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Sulfasalazine	Sulfasalazine	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Methimazole	Methimazole	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Nystatin	Nystatin	16	suppressed
Omeprazole	Omeprazole	16	suppressed
Primidone	Primidone	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	11
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Torsemide	Torsemide	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Estradiol	Estradiol	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Clonidine	Clonidine	11	suppressed
Famciclovir	Famciclovir	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error